Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Halozyme Therapeutics Inc. (NASDAQ: HALO) closed at $59.50 in the last session, down -4.51% from day before closing price of $62.31. In other words, the price has decreased by -$4.51 from its previous closing price. On the day, 1.72 million shares were traded. HALO stock price reached its highest trading level at $62.8 during the session, while it also had its lowest trading level at $59.1.
Ratios:
We take a closer look at HALO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.46. For the most recent quarter (mrq), Quick Ratio is recorded 6.21 and its Current Ratio is at 7.41. In the meantime, Its Debt-to-Equity ratio is 5.30 whereas as Long-Term Debt/Eq ratio is at 5.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $57 from $52 previously.
On June 07, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also upped its target price recommendation from $48 to $51.
On February 29, 2024, TD Cowen started tracking the stock assigning a Outperform rating and target price of $54.TD Cowen initiated its Outperform rating on February 29, 2024, with a $54 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 17 ’24 when LaBarre Michael J. sold 10,000 shares for $62.88 per share. The transaction valued at 628,780 led to the insider holds 173,756 shares of the business.
LaBarre Michael J. sold 10,000 shares of HALO for $620,316 on Sep 18 ’24. The SVP, CHIEF TECHNICAL OFFICER now owns 173,756 shares after completing the transaction at $62.03 per share. On Sep 18 ’24, another insider, MICHAEL LABARRE, who serves as the Officer of the company, bought 10,000 shares for $62.03 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HALO now has a Market Capitalization of 7892020736 and an Enterprise Value of 8541506560. As of this moment, Halozyme’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.07, and their Forward P/E ratio for the next fiscal year is 12.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.63 while its Price-to-Book (P/B) ratio in mrq is 26.01. Its current Enterprise Value per Revenue stands at 9.781 whereas that against EBITDA is 17.765.
Stock Price History:
Over the past 52 weeks, HALO has reached a high of $65.53, while it has fallen to a 52-week low of $32.83. The 50-Day Moving Average of the stock is 2.72%, while the 200-Day Moving Average is calculated to be 31.69%.
Shares Statistics:
According to the various share statistics, HALO traded on average about 1.30M shares per day over the past 3-months and 1150750 shares per day over the past 10 days. A total of 126.77M shares are outstanding, with a floating share count of 125.30M. Insiders hold about 1.09% of the company’s shares, while institutions hold 97.28% stake in the company. Shares short for HALO as of 1724976000 were 10040022 with a Short Ratio of 7.75, compared to 1722384000 on 8945252. Therefore, it implies a Short% of Shares Outstanding of 10040022 and a Short% of Float of 10.74.
